|
GB0426874D0
|
|
Auxiliary power supply for portable medical device
|
|
EP1117389A1
|
|
Method of making pressure sensitive adhesive matrix patches containing hydrophilic salts of drugs
|
|
WO9926571A1
|
|
Transdermal delivery devices containing polydiorganosiloxane polymers to regulate adhesive properties
|
|
AU9023198A
|
|
Incorporation of latent acid solubilizing agents in coated pellet formulations to obtain ph independent release
|
|
ZA9807181B
|
|
Conjugates targeted to the interleukin-2-receptor
|
|
AU7282698A
|
|
Targeted delivery to t lymphocytes
|
|
WO9834621A1
|
|
Composition and method for supplementing testosterone in women with symptoms of testosterone deficiency
|
|
KR20000035800A
|
|
Fatty acid esters of glycolic acid and its salts as permeation enhancers
|
|
WO9740792A1
|
|
Transdermal administration of steroid hormones using diethanolamides of c12-c18 fatty acids as permeation enhancers
|
|
ZA9702087B
|
|
Targeting macromolecular produgs to T lymphocytes.
|
|
US5985317A
|
|
Pressure sensitive adhesive matrix patches for transdermal delivery of salts of pharmaceutical agents
|
|
US5762953A
|
|
Transdermal propentofylline compositions for the treatment of Alzheimers disease
|
|
US5783208A
|
|
Transdermal drug delivery matrix for coadministering estradiol and another steroid
|
|
WO9619205A1
|
|
Transdermal delivery system with adhesive overlay and peel seal disc
|
|
US5766620A
|
|
Buccal delivery of glucagon-like insulinotropic peptides
|
|
US5849322A
|
|
Compositions and methods for buccal delivery of pharmaceutical agents
|
|
WO9608263A1
|
|
Intracellular delivery of chemical agents to a specific cell type
|
|
US5780050A
|
|
Drug delivery compositions for improved stability of steroids
|
|
US5601839A
|
|
Triacetin as a penetration enhancer for transdermal delivery of a basic drug
|
|
WO9524172A1
|
|
Drug-containing adhesive composite transdermal delivery device
|
